Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

5.5% Rise in July Exports is Fastest in 6 Months; Pharmaceuticals Lead Growth as Electronics Shipments Fall (Singapore)

This article was originally published in PharmAsia News

Executive Summary

Singapore exports expanded at their fastest pace in six months, as pharmaceuticals shipped to Europe and Japan offset a persistent slump in electronics. Non-oil domestic exports rose 5.5 per cent last month against the same period last year, accelerating from a 1.2 per cent increase in June. Sales of drug ingredients surged 45.3 per cent, leading a 20.3 per cent growth in non-electronics exports. In particular, shipments to Europe and Japan, where the chemicals are processed into pills and tablets, doubled. (Click here for more

You may also be interested in...



QUOTED. 18 September 2020. Ed Israelski.

The US FDA has been skeptical about remote testing, but independent consultant (and former Abbott human factors director) Ed Israelski predicts the pandemic may bring a change.

US Bill Urges Automatic Insulin Interchangeability

A draft Biosimilar Insulin Access Act, intended to waive US interchangeability requirements for FDA-approved biosimilar insulins, has been introduced by representative Glenn Grothman.

Ex-Cipla Executive To Helm JB Chemicals

The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.

UsernamePublicRestriction

Register

ID1132028

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel